Oxurion

Foundation date

30/05/2006

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Oxurion is dedicated to developing and commercializing new pharmacologic ophthalmic treatments that address important unmet clinical needs. By meeting this goal Oxurion intends to help patients around the world with a new or better treatment for their condition.

Upcoming events

Latest news

  • Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

    8 hours ago

  • Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology

    1 day ago

  • Fat creates an ideal environment for metastatic breast tumors

    1 day ago